A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1271143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Mona Shafaghi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Pneumococcal Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pneumococcus is an important respiratory pathogen that is associated with high rates of death in newborn children and the elderly. Given the disadvantages of current polysaccharide-based vaccines, the most promising alternative for developing improved vaccines may be to use protein antigens with different roles in pneumococcus virulence. PspA and PhtD, highly immunogenic surface proteins expressed by almost all pneumococcal strains, are capable of eliciting protective immunity against lethal infections.
Methods
In this study using immunoinformatics approaches, we constructed one fusion construct (called PAD) by fusing the immunodominant regions of PspA from families 1 & 2 (PA) to the immunodominant regions of PhtD (PD). The objective of this project was to test the immunogenicity of the fusion protein PAD and to compare its protective activity against S. pneumoniae infection with PA or PD alone and a combination of PA and PD. The prediction of physicochemical properties, antigenicity, allergenicity, toxicity, and 3D-structure of the constructs, as well as molecular docking with HLA receptor and immune simulation were performed using computational tools. Finally, mice were immunized and the serum levels of antibodies/cytokines and functionality of antibodies in vitro were evaluated after immunization. The mice survival rates and decrease of bacterial loads in the blood/spleen were examined following the challenge.
Results
The computational analyses indicated the proposed constructs could be antigenic, non-allergenic, non-toxic, soluble and able to elicit robust immune responses. The results of actual animal experiments revealed the candidate vaccines could induce the mice to produce high levels of antibodies and cytokines. The complement-mediated bactericidal activity of antibodies was confirmed and the antibodies provided favorable survival in immunized mice after bacterial challenge. In general, the experimental results verified the immunoinformatics studies.
Conclusion
For the first time this report presents novel peptide-based vaccine candidates consisting of immunodominant regions of PspA and PhtD antigens. The obtained findings confirmed that the fusion formulation could be relatively more efficient than the individual and combination formulations. The results propose that the fusion protein alone could be used as a serotype-independent pneumococcal vaccine or as an effective partner protein for a conjugate polysaccharide vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
- Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
- Drug Design and Bioinformatics Unit, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Zitieren
APA
Shafaghi, M., Bahadori, Z., Barzi, S. M., Afshari, E., Madanchi, H., Mousavi, S. F., & Shabani, A. A. (2023). A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1271143
Vancouver
Shafaghi M, Bahadori Z, Barzi SM, Afshari E, Madanchi H, Mousavi SF, et al. A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1271143
BibTeX
@article{Shafaghi2023,
author = {Shafaghi, Mona and Bahadori, Zohreh and Barzi, Seyed Mahmoud and Afshari, Elnaz and Madanchi, Hamid and Mousavi, Seyed Fazlollah and Shabani, Ali Akbar},
title = {A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1271143}
}
EUVIMED